Production (Stage)
Leap Therapeutics, Inc.
LPTX
$0.393
-$0.0022-0.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.44M | -15.67M | -18.18M | -20.13M | -13.82M |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | -100.00K | 5.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.32M | 1.91M | 1.45M | 1.57M | 1.36M |
| Change in Net Operating Assets | -363.00K | -1.76M | 1.12M | 4.99M | -3.07M |
| Cash from Operations | -14.48M | -15.51M | -15.60M | -13.67M | -15.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -77.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 16.00K | 104.00K | 0.00 | 40.00M | 29.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -66.00K | -2.88M | -- |
| Cash from Financing | -61.00K | 104.00K | -66.00K | 37.12M | 29.00K |
| Foreign Exchange rate Adjustments | 5.00K | -166.00K | 10.00K | 112.00K | -235.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.54M | -15.57M | -15.66M | 23.56M | -15.72M |